NVIDIA (NVDA, Financials) shares dropped 7.2% to $104.12 as of 12:11 p.m. Eastern on Wednesday, after UBS analyst Timothy Arcuri reaffirmed a Buy rating on the stock with a price target of $185, despite the company disclosing a $5.5 billion reserve linked to new U.S. export restrictions.
NVIDIA said its H20 chips, designed for artificial intelligence applications, now require U.S. export licenses for sales to China, Russia, and other countries subject to arms embargoes. The company booked the $5.5 billion reserve in anticipation of reduced revenue from these changes.
UBS estimated that removing the H20 chip line from financial models could lower earnings per share by roughly $0.20, though the firm has not revised its current projections.
Other analysts offered varied outlooks. Piper Sandler forecast fiscal year 2026 earnings per share at $3.45 and fiscal year 2027 at $5.08. Cantor Fitzgerald maintained a $200 target, Mizuho Securities set a $168 target, and Raymond James cut its target to $150 while maintaining a Strong Buy rating.
Arcuri said the licensing hurdle could serve as a clearing event, noting NVIDIAs plan to invest $500 billion in U.S. AI infrastructure over the next four years. The initiative may address national security concerns surrounding advanced AI technology exports.
Despite regulatory challenges, analysts continue to support NVIDIAs long-term strategy centered on Blackwell GPU development and AI market expansion.
This article first appeared on GuruFocus.免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。